24/7 BIOPHARMA - Issue 1 / March 2026

TWENTYFOURSEVENBIOPHARMA NEWS 96 66 DIPHARMA Proactively addressing nitrosamine risk in the pharmaceutical industry 70 SYNGENE Syngene’s advanced-modality platform takes centre stage in advanced biologics race 72 OFICHEM Ofichem focuses on European expansion as supply-chain fragility redefines API sector 74 FLAMMA Stop letting the proposal sell you the dream: A practical playbook for today’s CDMO market 78 THERMO FISHER SCIENTIFIC The new operational reality of drug development 82 DCAT ROUNDTABLE Redefining the value in partnerships ahead of DCAT Week

RkJQdWJsaXNoZXIy MjY2OTA4MA==